Hill-Rom (HRC) Stock Price, News & Analysis

Company Overview

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Key Stats

• Today's Range: $155.96 to $155.96
• 50-Day Range: $155.05 to $156.18
• 52-Week Range: $93.34 to $156.22
• Volume: N/A
• Average Volume: 656,912 shs
• Market Capitalization: $10.30 billion
• P/E Ratio: 41.92
• Dividend Yield: 0.62%
• Price Target: N/A
• Consensus Rating: N/A

Hill-Rom Stock Analysis - MarketRank™

Hill-Rom scored higher than 30% of companies evaluated by MarketBeat, and ranked 783rd out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Hill-Rom.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 11.49%

Earnings Growth

Earnings for Hill-Rom are expected to grow by 11.49% in the coming year, from $6.44 to $7.18 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Hill-Rom is 41.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.80.

Price to Earnings Ratio vs. Sector

The P/E ratio of Hill-Rom is 41.92, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.88.

Price to Book Value per Share Ratio

Hill-Rom has a P/B Ratio of 5.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for HRC.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Hill-Rom has a dividend yield of 0.62%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Hill-Rom does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Hill-Rom is 25.81%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Hill-Rom will have a dividend payout ratio of 13.37% next year. This indicates that Hill-Rom will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -1.10

Short Interest

There is no current short interest data available for HRC.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added Hill-Rom to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Hill-Rom insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.69% of the stock of Hill-Rom is held by insiders.

Percentage Held by Institutions

76.45% of the stock of Hill-Rom is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HRC Stock Analysis - Frequently Asked Questions

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) posted its quarterly earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.20. Hill-Rom's quarterly revenue was up 13.1% compared to the same quarter last year.

Does Hill-Rom have any subsidiaries?

Hill-Rom subsidiaries include these companies: Breathe Technologies, Voalte Inc, Mortara Instrument, Tridien Medical, Trumpf Medical Systems Ltd., Welch Allyn Inc., Virtus Inc., and others.

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), PayPal (PYPL), Meta Platforms (META) and Bank of America (BAC).

Company Calendar

• Last Earnings: 11/05/2021
• Today: 8/07/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:HRC
• Previous Symbol: NYSE:HB
• CIK: 47518
• Web: www.hill-rom.com
• Phone: (312) 819-7200
• Fax: 812-934-8189
• Employees: 10,000
• Year Founded: 1929

Profitability

• EPS (Trailing Twelve Months): $3.72
• Trailing P/E Ratio: 41.92
• Forward P/E Ratio: 24.22
• P/E Growth: N/A
• Net Income: $248.50 million
• Net Margins: 8.23%
• Pretax Margin: 10.03%
• Return on Equity: 23.07%
• Return on Assets: 8.96%

Debt

• Debt-to-Equity Ratio: 0.97
• Current Ratio: 1.38
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $3.02 billion
• Price / Sales: 3.41
• Cash Flow: $9.29 per share
• Price / Cash Flow: 16.79
• Book Value: $28.56 per share
• Price / Book: 5.46

Miscellaneous

• Outstanding Shares: 66,050,000
• Free Float: 65,594,000
• Market Cap: $10.30 billion
• Optionable: Optionable
• Beta: 0.55